A$1.3 billion investment to list life-saving medicines in Australia
The Australian government will invest A$1.3 billion ($1.02 billion) listing new medicines and vaccines that will save lives and help thousands of Australians manage debilitating conditions in its 2015-16 Budget.
Minister for Health Sussan Ley announced on Saturday that Tuesday’s Budget would list new drugs to help Australians beat melanoma, breast cancer and blindness on the Pharmaceutical Benefits Scheme (PBS).The government will also extend free vaccinations for the debilitating shingles virus to older Australians aged 70 to 79 by listing it on the National Immunization Program.
Ms Ley said the announcement was a key part of the Abbott government’s commitment to ensuring Australian patients had affordable access to medicines when and where they needed them. The listing of A$628 million worth of new cancer drugs also formed part of broader package measures to improve the detection, treatment and prevention of cancer in the Budget, she noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
| Headless Content Management with Blaze